Anne Michelle Whitaker

Anne Michelle Whitaker

Director/Board Member at ICON PUBLIC LIMITED COMPANY
58 year
Health Technology
Commercial Services
Electronic Technology

Profile

Anne Michelle Clem Whitaker is currently Chairman at QurAlis Corp.
since 2022.
Also holds director roles at Trinity Partners LLC, Bryn Pharma LLC, and Trinity Life Science Partners.
Serves as Independent Non-Executive Director at ICON plc starting 2024.
Trustee at the University of North Alabama since 2018.
Managing Partner at Anne Whitaker Group LLC since 2018.
Former roles include President, Chief Executive Officer & Director at Synta Pharmaceuticals Corp.
(2014–2015), Chief Executive Officer at Sanofi US Services, Inc., President, Chief Executive Officer & Director at KNOW Bio LLC, President, Chief Executive Officer & Director at Novoclem Therapeutics (2017–2018), Chief Executive Officer & Director at Aerami Therapeutics Holdings, Inc. and Aerami Therapeutics, Inc. (2018–2020), Chairman & Executive Vice President at Salix Pharmaceuticals Ltd. (2015–2017), Chairman & Executive Vice President at OraPharma, Inc., Chairman & Executive Vice President at Dendreon Corp.
(2015–2017), Vice Chairman & Treasurer at National Pharmaceutical Council (2012–2013), Group Chairman & Executive Vice President at Bausch Health Cos., Inc. (2015–2017), Independent Director at Wolfspeed, Inc. (2013–2021), Independent Director at OraSure Technologies, Inc. (2021–2023), Independent Non-Executive Director at Vectura Group Ltd. (2018–2020), Independent Director at Keenova Therapeutics Plc (2018–2022), Independent Non-Executive Director at UDG Healthcare Ltd. (Dublin) (2020–2021), Independent Non-Executive Director at Faron Pharmaceuticals Oy (2021–2023), Director at Madrigal Pharmaceuticals, Inc. (2014–2015), Independent Non-Executive Director at Ergomed Group Ltd. (2022–2023), and President-North America Pharmaceuticals at Sanofi (2011–2014).
Education includes undergraduate degree from the University of North Alabama.

Anne Michelle Whitaker active positions

CompaniesPositionStart
ICON PUBLIC LIMITED COMPANY Director/Board Member 22/07/2024
Trinity Life Science Partners
Director/Board Member -
Director/Board Member -
Director/Board Member -
Chairman 20/06/2022
Anne Whitaker Group LLC
Corporate Officer/Principal 31/03/2018
Director/Board Member 31/12/2017

Former positions of Anne Michelle Whitaker

CompaniesPositionEnd
TELIX PHARMACEUTICALS LIMITED Director/Board Member 28/04/2025
NYKODE THERAPEUTICS Director/Board Member 22/04/2025
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Anne Michelle Whitaker's experience

Training of Anne Michelle Whitaker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

59

1st degree connections

36

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies36

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Communications

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Anne Whitaker Group LLC

Health Technology

Trinity Life Science Partners

Technology Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Anne Michelle Whitaker